Table of contents

  • Preliminary material
    • Title and verso pages
    • Contents
    • Acknowledgments
    • Abbreviations
    • Summary
  • Body section
    • 1 Introduction
      • 1.1 Why have guidelines?
      • 1.2 Why monitor the safety of these guidelines?
      • 1.3 How has the safety of the guidelines been monitored?
    • 2 Consideration of background trends in cervical abnormalities and cancer
      • 2.1 Cervical abnormalities detected by cytology
      • 2.2 Cervical abnormalities detected by histology
      • 2.3 Women with high-grade abnormalities detected by histology (high-grade abnormality
      • detection rate)
      • 2.4 Cervical cancer incidence
    • 3 Outcomes of projects to assess the safety of the guidelines
      • 3.1 Are women with a pre-invasive cervical abnormality more likely to be diagnosed with a
      • subsequent cervical cancer since the introduction of the guidelines?
      • 3.3 What did the review of cervical cancer cases included in the analyses reveal?
      • 3.4 What did the survey of pathology laboratories reporting cervical cytology show?
      • 3.5 What did the compliance study reveal?
    • 4 Discussion
  • End matter
    • Appendixes
      • Appendix A Additional tables
      • Appendix B Data sources
      • Appendix C Data quality statement: Cervical screening safety monitoring data
      • Appendix D Statistical methods
    • References
    • List of tables
    • List of figures
Previous page